GB

Ghanashyam Biswas

Active Director Director DIN 03512635
DIN 03512635 First appointment May 2007 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies –
Total affiliations 6 Since May 2007
Shareholding value •••• Premium profile

About Ghanashyam Biswas

Data last updated:

Ghanashyam Biswas has 19 years in corporate governance. Holds Director and Additional Director roles. Currently with 6 companies, including Sparsh Optimum Healthcare Private Limited and Swasth Bhoomi Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹91.24 Cr; the largest is Sparsh Hospitals & Critical Care Private Limited at ₹89.76 Cr (FY 2024).

DIN 03512635
Primary Designation Director
First Appointment 10 May 2007
Oldest Company Age 43 yrs
Largest company Sparsh Hospitals & Critical Care Private Limited · ₹89.76 Cr (FY 2024)
Combined revenue ₹91.24 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20072007₹89.76 Cr (FY 2024)Active
Director20 Dec 20121982₹87.5 Lakh (FY 2024)Active
Swasth Bhoomi Private Limited U74999DL2019PTC351924
Director27 Jun 20192019₹35.1 Lakh (FY 2025)Active
Utkal Cancer Care Private Limited U74999OR2020PTC032629
Director06 Nov 20232020₹17.5 Lakh (FY 2025)Active
Eva Biologics Private Limited U85300OR2020PTC034152
Additional Director02 Aug 20212020₹8 Lakh (FY 2023)Active
Designated Partner05 Mar 20242024–Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sparsh Optimum Healthcare Private Limited
Swasth Bhoomi Private Limited
Sparsh Hospitals & Critical Care Private Limited
Eva Biologics Private Limited
Premium access

Shareholding and investment profile for Ghanashyam Biswas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ghanashyam Biswas

Ghanashyam Biswas has 19 years in corporate governance. Holds Director and Additional Director roles. Currently with 6 companies, including Sparsh Optimum Healthcare Private Limited and Swasth Bhoomi Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹91.24 Cr; the largest is Sparsh Hospitals & Critical Care Private Limited at ₹89.76 Cr (FY 2024).

Ghanashyam Biswas is associated with 6 companies as Director and Additional Director, including Sparsh Hospitals & Critical Care Private Limited (₹89.76 Cr), Sparsh Optimum Healthcare Private Limited (₹87.5 Lakh), Swasth Bhoomi Private Limited (₹35.1 Lakh).

Ghanashyam Biswas has expertise in Healthcare, General Business.

Ghanashyam Biswas has 19 years in corporate governance.

By reported revenue, the largest current company of Ghanashyam Biswas is Sparsh Hospitals & Critical Care Private Limited, with revenue of ₹89.76 Cr (FY 2024).

The 5 current companies of Ghanashyam Biswas that report revenue have a combined latest revenue of ₹91.24 Cr.

Ghanashyam Biswas currently holds positions at 6 companies; the 5 largest by reported revenue are Sparsh Hospitals & Critical Care Private Limited (₹89.76 Cr), Sparsh Optimum Healthcare Private Limited (₹87.5 Lakh), Swasth Bhoomi Private Limited (₹35.1 Lakh), Utkal Cancer Care Private Limited (₹17.5 Lakh), Eva Biologics Private Limited (₹8 Lakh).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available